Polypropylene hernia mesh products from multiple manufacturers have caused serious complications including adhesions, perforations, infections, and mesh migration. The major MDLs are in mature or settlement phases. C.R. Bard/Davol, Ethicon/J&J, and Covidien/Medtronic have all faced mass tort claims. New cases from recent revision surgeries may still qualify under the discovery rule.
Polypropylene mesh degrades, shrinks, and stiffens after implantation, causing chronic pain, recurrence, bowel obstruction, and erosion into adjacent structures. The injury mechanism is well-established through bellwether trials and expert testimony. Strongest remaining cases involve recent revision surgeries and specific high-risk mesh products.
The major hernia mesh MDLs are in settlement or wind-down phases. Bard/Davol has resolved thousands of cases. Ethicon and Covidien settlements ongoing. New cases limited to recent revision surgeries.